Silvant Capital Management’s Loxo Oncology, Inc LOXO Stock Holding History

Silvant Capital Management’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,975	Closed	-$417K	–	347
2018 Q4	$417K	Hold	2,975	–	–	0.08%	120
2018 Q3	$508K	Hold	2,975	–	–	0.06%	124
2018 Q2	$516K	Hold	2,975	–	–	0.06%	116
2018 Q1	$343K	Buy	+2,975	New	+$316K	0.04%	150

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Silvant Capital Management's LOXO Position: Q1 2019 in Review

Silvant Capital Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 2,975 shares — an estimated $417K sold.

Silvant Capital Management first reported a position in LOXO in Q1 2018 and held it in 4 quarters. The position peaked at $516K in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Silvant Capital Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Silvant Capital Management sold 2,975 Loxo Oncology, Inc shares in Q1 2019, an estimated $417K.
Silvant Capital Management first reported a position in Loxo Oncology, Inc in Q1 2018 and held it in 4 quarters.
Silvant Capital Management's Loxo Oncology, Inc position peaked at $516K in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Silvant Capital Management's 13F filing for Q1 2019, filed 10 May 2019.